mHealth Market Research Report- Forecast To 2030

mHealth Market Information, By Therapeutics(respiratory, mental and neurological disorders, fitness & lifestyle) Application(monitoring, diagnosis & treatment, wellness & prevention) - Forecast to 2030

ID: MRFR/HCIT/1284-HCR | February 2023 | Region: Global | 301 Pages         

1 REPORT SCOPE

1.1 SCOPE OF THE STUDY

1.1.1 MOBILE HEALTH (MHEALTH): REPORT COVERAGE

1.1.2 XX RESEARCH METHODOLOGY

1.1.3 RESEARCH METHODOLOGY FOR THE GLOBAL MARKET STUDY

1.1.3.1 Geographical Analysis

1.1.3.2 Demand Side & Supply Side Analysis

1.1.3.3 Data Synthesis & Bridging

1.1.4 GLOBAL MOBILE HEALTH (MHEALTH): RESEARCH METHODOLOGY

1.1.5 KEY DATA POINT SOURCES

1.1.5.1 Data Points taken from Secondary Sources

1.1.5.2 Data Points taken from Primary Sources

1.1.6 REPORT DESCRIPTION

2 EXECUTIVE SUMMARY

3 MARKET OVERVIEW

3.1 INTRODUCTION

3.2 MARKET DYNAMICS

3.2.1 MARKET DRIVERS

3.2.1.1 Patients Involvement in personal healthcare

3.2.1.2 Proliferation of Smartphones and wearable devices into healthcare

3.2.1.3 Integration of wireless technologies with portable healthcare devices

3.2.1.4 Introduction of connected healthcare solutions in the mHealth market

3.2.1.5 Benefits of Cost effectiveness and Patients’ Convenience

3.2.1.6 Increase in Lifestyle Disease

3.2.2 MARKET CHALLENGES

3.2.2.1 Low rate of literacy and language barriers in low- and middle-income countries (LMICs)

3.2.2.2 Invasion of Privacy

3.2.2.2.1 Security Breach Cases

3.2.2.2.2 Potential risk of Hardware or Software failure

3.2.2.2.3 Stringent Regulations and Standards

3.2.2.2.4 Lack of Awareness about the possible applications of mHealth

3.2.3 MARKET OPPORTUNITIES

3.2.3.1 Partnership: An entry mode

3.2.3.2 Introduction of mHealth in developing economies

4 INDUSTRY DYNAMICS

4.1 MHEALTH MARKET TIMELINE

4.2 VALUE CHAIN OF THE MHEALTH MARKET

4.2.1.1 Device Manufacturers

4.2.1.2 App Developers

4.2.1.3 Network providers/ Mobile operators

4.2.1.4 Healthcare providers and Pharmaceuticals

4.2.1.5 Patients

4.2.1.6 Consortiums, Certification, Regulations, & Standards

4.2.1.6.1 Introduction

4.2.1.6.2 Consortiums

4.2.1.6.3 Alliance/Associations

4.2.1.6.4 Regulatory Bodies

4.2.1.7 Food and Drug Administration (FDA)

4.2.1.8 Medical Device Regulation Act

4.2.1.9 Medical Mobile Application(MMA)

4.2.2 CERTIFICATION

4.2.3 MHEALTH DEVICE: PORTER’S FIVE FORCE ANALYSIS

4.2.4 BARGAINING POWER OF BUYER

4.2.5 BARGAINING POWER OF SUPPLIER

4.2.6 THREAT FROM SUBSTITUTE

4.2.7 THREAT FROM A NEW ENTRANT

4.2.8 INTENSITY OF COMPETITIVE RIVALRY

5 GLOBAL MHEALTH MARKET ECOSYSTEM

5.1 INTRODUCTION

5.1.1 MHEALTH DEVICES

5.1.2 MEDICAL DEVICES

5.1.2.1 SMBG monitor

5.1.2.1.1 SMBG Device Types& Uses

5.1.2.1.2 Diseases Managed by SMBG Device

5.1.2.1.3 Key players

5.1.2.2 Blood Pressure (BP) Monitor

5.1.2.2.1 BP Monitor Device Types & Uses

5.1.2.2.2 Diseases Managed by BP Monitor Device

5.1.2.2.3 Key players

5.1.2.2.4 Pulse Oximeter

5.1.2.2.5 Pulse Oximeter : Types & Uses

5.1.2.2.6 Diseases Managed by Pulse Oximeter Device

5.1.2.2.7 Key players

5.1.2.3 Cardiac Monitors

5.1.2.3.1 Diseases Managed by Cardiac Monitors

5.1.2.3.2 Disease Management Devices Types

5.1.2.3.3 Cardiac Monitor Uses

5.1.2.4 Key players

5.1.2.5 Other medical devices

5.1.2.5.1 Health and Fitness Devices

5.1.2.5.2 Hand Worn Products

5.1.2.5.2.1 Smart Watch

5.1.2.5.2.2 Wrist Wear

5.1.2.5.3 Key players

5.1.2.5.4 Head Worn Products

5.1.2.5.4.1 AR/VR HMD/HUD

5.1.2.5.4.2 Others

5.1.2.5.4.3 Body worn products

5.1.2.5.4.4 Smart Textile

5.1.2.5.4.5 Wearable Patch

5.1.2.5.4.6 Others

5.1.2.5.5 Non-Clinical applications

5.1.2.5.6 Clinical Application

5.1.2.6 Others Devices

5.1.2.6.1 Mobile telemedicine/tele-care devices

5.1.2.6.2 Home care devices

5.1.2.6.2.1 Vessyl

5.1.2.6.2.2 TAO

5.1.2.6.2.3 CubeSensors

5.1.2.6.2.4 Kolibree

5.1.2.6.2.5 TellSpec

5.1.2.6.2.6 Kinsa

5.1.2.6.2.7 Beddit

5.1.2.6.2.8 Wello iPhone Case

5.1.2.6.3 Key Participants

5.1.2.7 mHealth Services

5.1.3 MOBILE HEALTH APPS AND CONTENT SOLUTION

5.1.3.1 Software

5.1.3.2 Big data

5.1.3.3 Key Market Trends, Developments and Participants

5.1.3.3.1 Market Trends and Market Developments

5.1.3.3.2 Key Participants

5.1.4 NETWORK AND SERVICES/ MOBILE OPERATORS

5.1.4.1 Benefits of network & Services

5.1.4.2 Key Market Trends, Developments and Participants

5.1.4.2.1 Market Trends and Market Developments

5.1.4.2.2 Key Participants

5.1.5 HEALTHCARE AND PHARMACEUTICALS

5.1.5.1 Healthcare providers

5.1.5.2 Pharmaceuticals

5.1.5.2.1 Key Market Trends, Developments and Participants

5.1.5.2.1.1 Market Trends and Market Developments

5.1.5.2.1.2 Key Participants

6 GLOBAL MHEALTHMARKET – THERAPEUTICS

6.1 INTRODUCTION

6.1.1 GLOBAL MARKET STATISTICS

6.1.1.1 Cardiovascular Diseases

6.1.2 DEVICES

6.1.3 APPS

6.1.4 KEY PLAYERS

6.2 DIABETES

6.2.1 DEVICES

6.2.2 APPS

6.2.3 KEY PLAYERS

6.3 RESPIRATORY

6.3.1 DEVICES

6.3.2 APPS

6.3.3 KEY PLAYERS

6.4 MENTAL AND NEUROLOGICAL DISORDERS

6.4.1 DEVICES

6.4.2 APPS

6.4.3 KEY PLAYERS

6.5 FITNESS & LIFESTYLE THERAPEUTICS

6.5.1 DEVICES

6.5.2 APPS

6.5.3 KEY PLAYERS

6.6 OTHERS

7 GLOBAL MHEALTHMARKET – APPLICATION/ SOLUTION TYPE

7.1 INTRODUCTION

7.1.1 MONITORING APPLICATIONS

7.1.1.1 Key Participants

7.1.2 DIAGNOSIS & TREATMENT

7.1.2.1 Key Participants

7.1.3 EDUCATION AND AWARENESS

7.1.3.1 Key Participants

7.1.4 HEALTHCARE MANAGEMENT

7.1.5 WELLNESS & PREVENTION

7.1.6 OTHERS/ OTHER SERVICES AND APPLICATIONS MARKET

7.1.7 REMOTE DATA COLLECTION

7.1.7.1 Key Market Developments

8 GLOBAL MHEALTH MARKET–GEOGRAPHY

8.1 INTRODUCTION

8.1.1 MARKET STATISTICS

8.1.2 THE AMERICAS

8.1.3 NORTH AMERICA

8.1.3.1 U.S.

8.1.3.1.1 Key Market trends, Developments and Participants

8.1.3.1.1.1 Key Market Trends and Developments

8.1.3.1.1.2 Key Participants

8.1.3.2 Canada

8.1.3.2.1 Key Market Trend

8.1.3.2.2 Key players

8.1.3.3 South America

8.1.3.3.1 Constraints

8.1.3.3.2 Key Market Trends, Developments and Participants

8.1.3.3.2.1 Market Trends and Market Developments

8.1.3.3.2.2 Key Participants

8.1.4 ASIA-PACIFIC (APAC)

8.1.4.1 Key Drivers in APAC

8.1.4.1.1 Key Market Trends, Developments and Participants

8.1.4.1.1.1 Market Trends & Development

8.1.4.1.1.2 Key Participants

8.1.4.2 CHINA

8.1.4.3 JAPAN

8.1.4.4 AUSTRALIA

8.1.4.5 INDIA

8.1.5 EUROPE

8.1.5.1 Key Market Trends, Developments and Participants

8.1.5.2 The U.K.

8.1.5.3 Germany

8.1.5.4 Key Participants

8.1.6 REST OF THE WORLD (ROW)

8.1.6.1 Africa

8.1.6.1.1 Key Market Trends, Developments and Participants

8.1.6.1.1.1 Market Trends and Market Developments

8.1.6.1.2 Key Participants

8.1.7 MIDDLE EAST

8.1.7.1 Key Market Trends, Developments and Participants

8.1.7.1.1 Market Trends and Market Developments

8.1.7.1.2 Key Participants

9 KEY MARKET DEVELOPMENT AND STRATEGIES

9.1 INTRODUCTION

9.1.1 PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS

9.1.2 MERGERS & ACQUISITIONS

9.1.3 PRODUCT DEVELOPMENT AND LAUNCH

9.1.4 BUSINESS EXPANSION/CONTRACTS

9.1.5 PATENTS, APPROVALS AND CERTIFICATIONS

9.1.6 OTHERS (EVENTS & RECOGNITIONS)

10 COMPANY PROFILES

1.1 AGAMATRIX, INC.

10.1.1 OVERVIEW

10.1.2 FINANCIALS

10.1.3 KEY DEVELOPMENTS

10.2 ALIVECOR, INC.

10.2.1 OVERVIEW

10.2.2 FINANCIALS

10.2.3 KEY DEVELOPMENTS

10.3 APPLE, INC.

10.3.1 OVERVIEW

10.3.2 FINANCIALS

10.3.2.1 Overall Financials

10.3.2.2 Financials By Segment

10.3.2.3 Financials By Region

10.3.2.4 Financial Summary

10.3.3 KEY DEVELOPMENT

10.4 ATHENAHEALTH INC.

10.4.1 OVERVIEW

10.4.2 FINANCIALS

10.4.2.1 Overall Financials

10.4.2.2 Financial by Segments

10.4.2.3 Financial Summary

10.4.3 KEY DEVELOPMENT

10.5 AT&T, INC.

10.5.1 OVERVIEW

10.5.2 FINANCIALS

10.5.2.1 Overall Financials

10.5.2.2 Financials By Segment

10.5.2.3 Financial Summary

10.5.3 KEY DEVELOPMENTS

10.6 BIOTELEMETRY, INC. (CARDIONET)

10.6.1 OVERVIEW

10.6.2 FINANCIALS

10.6.2.1 Overall Financials

10.6.2.2 Financials by Segment

10.6.2.3 Financial Summary

10.6.3 KEY DEVELOPMENTS

10.7 GE HEALTHCARE

10.7.1 OVERVIEW

10.7.2 FINANCIALS

10.7.2.1 Overall Financials

10.7.2.2 Financials by Segment

10.7.2.3 Financial Summary

10.7.3 KEY DEVELOPMENTS

10.8 GOOGLE INC.

10.8.1 OVERVIEW

10.8.2 FINANCIALS

10.8.2.1 Financial Summary

10.8.3 KEY DEVELOPMENTS

10.9 JAWBONE, INC.

10.9.1 OVERVIEW

10.9.2 FINANCIALS

10.9.3 KEY DEVELOPMENTS

10.1 JOHNSON & JOHNSON

10.10.1 OVERVIEW

10.10.2 FINANCIALS

10.10.2.1 Overall Financials

10.10.2.2 Net Revenue By Segment

10.10.2.3 Net revenue by Region

10.10.3 KEY DEVELOPMENTS

10.11 LABORATORY CORPORATION OF AMERICA HOLDINGS

10.11.1 OVERVIEW

10.11.2 FINANCIALS

10.11.2.1 Overall Financials

10.11.2.2 Financials by Segment

10.11.2.3 Financial Summary

10.11.3 KEY DEVELOPMENTS

10.12 MEDTRONIC PLC

10.12.1 OVERVIEW

10.12.2 FINANCIALS

10.12.2.1 Overall Financials

10.12.2.2 Financial Summary

10.12.3 KEY DEVELOPMENTS

10.13 NIKE INC.

10.13.1 OVERVIEW

10.13.2 FINANCIALS

10.13.2.1 Overall Financials

10.13.2.2 Financials by Segments

10.13.2.3 Financial Summary

10.13.3 KEY DEVELOPMENTS

10.14 PFIZER

10.14.1 OVERVIEW

10.14.2 FINANCIALS

10.14.2.1 Overall Financials

10.14.2.2 Financials by Segment

10.14.2.3 Financials By Region

10.14.2.4 FINANCIAL SUMMARY

10.14.3 KEY DEVELOPMENTS

10.15 PHILIPS HEALTHCARE

10.15.1 OVERVIEW

10.15.2 FINANCIALS

10.15.2.1 Overall Financials

10.15.2.2 Financials By Region

10.15.2.3 Financials By Segment

10.15.2.4 Financial Summary

10.15.3 KEY DEVELOPMENTS

10.16 QUALCOMM, INC.

10.16.1 OVERVIEW

10.16.2 FINANCIALS

10.16.2.1 Overall Financials

10.16.2.2 Financials By Segment

10.16.2.3 Financials By Region

10.16.2.4 Financial Summary

10.16.3 KEY DEVELOPMENTS

10.17 QUEST DIAGNOSTICS INC.

10.17.1 OVERVIEW

10.17.2 FINANCIALS

10.17.2.1 Overall Financials

10.17.2.2 Financials by Segment

10.17.2.3 Financial Summary

10.17.3 KEY DEVELOPMENTS

10.18 ROCHE HOLDING AG-BR

10.18.1 OVERVIEW

10.18.2 FINANCIALS

10.18.2.1 Overall Financials

10.18.2.2 Financials by Segment

10.18.2.3 Financial Summary

10.18.3 KEY DEVELOPMENTS

10.19 SAMSUNG ELECTRONICS CO. LTD.

10.19.1 OVERVIEW

10.19.2 FINANCIALS

10.19.2.1 Overall financials

10.19.2.2 Financial Summary

10.19.3 KEY DEVELOPMENTS

10.2 SANOFI PHARMA

10.20.1 OVERVIEW

10.20.2 FINANCIALS

10.20.2.1 Overall Financials

10.20.3 FINANCIALS BY SEGMENT

10.20.4 FINANCIAL SUMMARY

10.20.5 KEY DEVELOPMENTS

10.21 WITHINGS SAS

10.21.1 OVERVIEW

10.21.2 FINANCIALS

10.21.3 KEY DEVELOPMENTS

 

LIST OF TABLES


TABLE 1L EADING COMPANIES IN THE MHEALTH MARKET

TABLE 2 SECURITY BREACHMENT CASES/ DEVELOPMENTS (2020-2027)

TABLE 3 MHEALTH INDUSTRY: KEY PARTNERSHIPS

TABLE 4 VALUE CHAIN: KEY PARTICIPANTS OFECOSYSTEM

TABLE 5 CONSORTIUMS IN MHEALTH MARKET

TABLE 6 ALLIANCE/ASSOCIATIONS IN MHEALTH MARKET

TABLE 7 REGULATORY BODIES IN MHEALTH MARKET

TABLE 8 MHEALTH MARKET CERTIFICATIONS

TABLE 9 FACTORS IMPACTING THE BUYER’S BARGAINING POWER

TABLE 10 FACTORS IMPACTING THE SUPPLIER’S BARGAINING POWER

TABLE 11 FACTORS IMPACTING THE THREAT FROM SUBSTITUTE

TABLE 12 FACTORS IMPACTING THE THREAT FROM NEW ENTRANT

TABLE 13 FACTORS IMPACTING THE DEGREE OF COMPETETION

TABLE 14 GLOBAL MHEALTH MARKET VALUE, BY ECOSYSTEM, 2020-2027 ($MILLION)

TABLE 15 GLOBAL MHEALTH DEVICE MARKET VALUE, BY DEVICE TYPE, 2020-2027 ($MILLION)

TABLE 16 GLOBAL MHEALTH DEVICE MARKET VALUE, BY APPLICATION TYPE 2020-2027 ($MILLION)

TABLE 17 GLOBAL MHEALTH SERVICE MARKET VALUE, BY SERVICE TYPE, 2020-2027 ($MILLION)

TABLE 18 GLOBAL MHEALTHSERVICES MARKET VALUE, BY APPLICATION TYPE 2027-2027 ($MILLION)

TABLE 19 KEY DEVELOPMENTS

TABLE 20 NETWORK & SERVICES: KEY DEVELOPMENTS

TABLE 21 PHARMACEUTICALS SERVICE: KEY DEVELOPMENT

TABLE 22 GLOBAL MHEALTHMARKET VALUE, BY THERAPEUTICS, 2020-2027 ($MILLION)

TABLE 23 CARDIOVASCULAR DISEASE: GLOBAL MHEALTHMARKET VALUE, BY APPLICATION, 2020-2027 ($MILLION)

TABLE 24 CARDIOVASCULAR DISEASE: GLOBAL MHEALTHMARKET VALUE, BY GEOGRAPHY, 2020-2027 ($MILLION)

TABLE 25 TYPE OF APP

TABLE 26 KEY DEVELOPMENTS

TABLE 27 DIABETES: GLOBAL MHEALTHMARKET VALUE, BY APPLICATION, 2020-2027 ($MILLION)

TABLE 28 DIABETES: GLOBAL MHEALTHMARKET VALUE, BY GEOGRAPHY, 2020-2027 ($MILLION)

TABLE 29 KEY DEVELOPMENTS

TABLE 30 RESPIRATORY DISEASE: GLOBAL MHEALTHMARKET VALUE, BY APPLICATION, 2020-2027 ($MILLION)

TABLE 31 RESPIRATORY DISEASE: GLOBAL MHEALTHMARKET VALUE, BY GEOGRAPHY, 2020-2027 ($MILLION)

TABLE 32 NEUROLOGY/ MENTAL HEALTH: GLOBAL MHEALTHMARKET VALUE, BY APPLICATION, 2020-2027 ($MILLION)

TABLE 33 NEUROLOGY/ MENTAL HEALTH: GLOBAL MHEALTHMARKET VALUE, BY GEOGRAPHY, 2020-2027 ($MILLION)

TABLE 34 FITNESS & LIFESTYLE: GLOBAL MHEALTHMARKET VALUE, BY APPLICATION, 2020-2027 ($MILLION)

TABLE 35 FITNESS & LIFESTYLE: GLOBAL MHEALTH MARKET VALUE, BY GEOGRAPHY, 2020-2027 ($MILLION)

TABLE 36 OTHER DISEASES: GLOBAL MHEALTH MARKET VALUE, BY APPLICATION, 2020-2027 ($MILLION)

TABLE 37 OTHER DISEASES: GLOBAL MHEALTH MARKET VALUE, BY GEOGRAPHY, 2020-2027 ($MILLION)

TABLE 38 GLOBAL MHEALTH MARKET VALUE, BY APPLICATION, 2020-2027 ($MILLION)

TABLE 39 MONITORING APPLICATIONS: GLOBAL MHEALTH MARKET VALUE, BY ECOSYSTEM, 2020-2027 ($MILLION)

TABLE 40 MONITORING APPLICATIONS: GLOBAL MHEALTH MARKET VALUE, BY THERAPEUTICS, 2020-2027 ($MILLION)

TABLE 41 MONITORING APPLICATIONS: GLOBAL MHEALTH MARKET VALUE, BY GEOGRAPHY, 2020-2027 ($MILLION)

TABLE 42 REMOTE MONITORING IN GEOGRAPHIES

TABLE 43 DIAGNOSIS & TREATMENTS: GLOBAL MHEALTH MARKET VALUE, BY ECOSYSTEM, 2020-2027 ($MILLION)

TABLE 44 DIAGNOSIS & TREATMENTS: GLOBAL MHEALTH MARKET VALUE, BY THERAPEUTICS, 2027-2027 ($MILLION)

TABLE 45 DIAGNOSIS & TREATMENTS: GLOBAL MHEALTH MARKET VALUE, BY GEOGRAPHY, 2027-2027 ($MILLION)

TABLE 46 DIAGNOSIS AND TREATMENT IN GEOGRAPHIES

TABLE 47 EDUCATION & AWARENESSS: GLOBAL MHEALTH MARKET VALUE, BY ECOSYSTEM, 2027-2027 ($MILLION)

TABLE 48 EDUCATION & AWARENESSS: GLOBAL MHEALTH MARKET VALUE, BY THERAPEUTICS, 2020-2027 ($MILLION)

TABLE 49 EDUCATION & AWARENESSS: GLOBAL MHEALTH MARKET VALUE, BY GEOGRAPHY, 2020-2027 ($MILLION)

TABLE 50 EDUCATION & WELLNESS IN GEOGRAPHIES

TABLE 51 HEALTHCARE MANAGEMENTS: GLOBAL MHEALTH MARKET VALUE, BY ECOSYSTEM, 2020-2027 ($MILLION)

TABLE 52 HEALTHCARE MANAGEMENTS: GLOBAL MHEALTH MARKET VALUE, BY THERAPEUTICS, 2020-2027 ($MILLION)

TABLE 53 HEALTHCARE MANAGEMENTS: GLOBAL MHEALTH MARKET VALUE, BY GEOGRAPHY, 2020-2027 ($MILLION)

TABLE 54 HEALTHCARE MANAGEMENT IN GEOGRAPHIES

TABLE 55 WELLNESS & PREVENTIONS: GLOBAL MHEALTH MARKET VALUE, BY ECOSYSTEM, 2020-2027 ($MILLION)

TABLE 56 WELLNESS & PREVENTIONS: GLOBAL MHEALTH MARKET VALUE, BY THERAPEUTICS, 2020-2027 ($MILLION)

TABLE 57 WELLNESS & PREVENTIONS: GLOBAL MHEALTH MARKET VALUE, BY GEOGRAPHY, 2020-2027 ($MILLION)

TABLE 58 WELLNESS & PREVENTION APPLLICATIONS IN DIFFERENT GEOGRAPHIES

TABLE 59 OTHERS APPLICATIONSS: GLOBAL MHEALTH MARKET VALUE, BY ECOSYSTEM, 2020-2027 ($MILLION)

TABLE 60 OTHERS APPLICATIONS: GLOBAL MHEALTH MARKET VALUE, BY THERAPEUTICS, 2020-2027 ($MILLION)

TABLE 61 OTHERS APPLICATIONSS: GLOBAL MHEALTH MARKET VALUE, BY GEOGRAPHY, 2020-2027 ($MILLION)

TABLE 62 MHEALTH: KEY DEVELOPMENTS (2020- 2027)

TABLE 63 GLOBAL MHEALTH MARKET VALUE, BY GEOGRAPHY, 2020-2027 ($MILLION)

TABLE 64 THE AMERICAS: MHEALTH MARKET VALUE, BY REGIONS, 2020-2027 ($MILLION)

TABLE 65 THE AMERICAS: MHEALTH MARKET VALUE, BY THERAPEUTICS, 2020-2027 ($MILLION)

TABLE 66 THE AMERICAS: MHEALTH MARKET VALUE, BY APPLICATION, 2020-2027 ($MILLION)

TABLE 67 THE U.S.: KEY DEVELOPMENTS

TABLE 68 SOUTH AMERICA: MHEALTH MARKET DEVELOPMENT (2020-2027)

TABLE 69 APAC: MHEALTH MARKET VALUE, BY THERAPEUTICS, 2020-2027 ($MILLION)

TABLE 70 APAC: MHEALTH MARKET VALUE, BY APPLICATION, 2020-2027 ($MILLION)

TABLE 71 KEY DEVELOPMENTS IN APAC

TABLE 72 EUROPE: MHEALTH MARKET VALUE, BY THERAPEUTICS, 2020-2027 ($MILLION)

TABLE 73 EUROPE: MHEALTH MARKET VALUE, BY APPLICATION, 2020-2027 ($MILLION)

TABLE 74 EUROPE: MHEALTH MARKET DEVELOPMENT

TABLE 75 ROW: MHEALTH MARKET VALUE, BY REGIONS, 2020-2027 ($MILLION)

TABLE 76 ROW: MHEALTH MARKET VALUE, BY THERAPEUTICS, 2020-2027 ($MILLION)

TABLE 77 ROW: MHEALTH MARKET VALUE, BY APPLICATION, 2020-2027 ($MILLION)

TABLE 78 AFRICA: MHEALTH MARKET DEVELOPMENTS (2020-2027)

TABLE 79 MIDDLE EAST: MHEALTH MARKET DEVELOPMENTS (2020-2027)

 

LIST OF FIGURES


FIGURE 1 MHEALTH MARKET STUDY: COVERAGE AREA

FIGURE 2 XX RESEARCH METHODOLOGY

FIGURE 3 DIFFERENT PHASES OF RESEARCH METHODOLOGY FOR THE GLOBAL MARKET

FIGURE 4 MHEALTH MARKET: RESEARCH METHODOLOGY

FIGURE 5 GLOBAL MHEALTH MARKET, BY ECOSYSTEM, 2020-2027 ($MILLION)

FIGURE 6 GLOBAL MHEALTH MARKET, BY THERAPEUTICS, 2020-2027 ($MILLION)

FIGURE 7 GLOBAL MHEALTH MARKET, BY APPLICATION, 2020-2027 ($MILLION)

FIGURE 8 GLOBAL MHEALTH MARKET, BY GEOGRAPHY, 2020-2027 ($MILLION)

FIGURE 9 MARKET DRIVERS AND CHALLENGES

FIGURE 10 MHEALTH MARKET DRIVERS: IMPACT ANALYSIS

FIGURE 11 BENEFITS OF MHEALTH TO PATIENTS

FIGURE 12 EXAMPLES OF EXISTING MHEALTH INNOVATIONS

FIGURE 13 MHEALTH MARKET CHALLENGES: IMPACT ANALYSIS

FIGURE 14 MAJOR BARRIERS CAUSED BY REGULATION AND STANDARDS

FIGURE 15 VALUE CHAIN

FIGURE 16 ROLES AND RESPONSIBILITIES OF HEALTHCARE POLICY MAKERS

FIGURE 17 CLASSIFICATION OF MEDICAL DEVICES

FIGURE 18 MHEALTH MARKET: PORTER FIVE FORCE ANALYSIS

FIGURE 19 MHEALTH ECOSYSTEM

FIGURE 20 TYPE OF MHEALTH DEVICES

FIGURE 21 SMBD DEVICE USES

FIGURE 22 USES OF BP MONITORING DEVICE

FIGURE 23 PULSE OXIMETER USES

FIGURE 24 WEARABLE DEVICE COMPONENTS

FIGURE 25 TYPE OF WEARABLE ELECTRONICS DEVICES

FIGURE 26 HAND WORN MHEALTH DEVICES

FIGURE 27 APPLE WATCH FIGURE

FIGURE 28 LEADING FITNESS TRACKING WRIST BANDS

FIGURE 29 GOOGLE’S CONTACT LENS

FIGURE 30 HEAD WORN DEVICES

FIGURE 31 ELECTRONIC FINGERTIP

FIGURE 32 COMPONENTS OF BIOSTAMP

FIGURE 33 MYO ARMBAND BY THALMIC LABS

FIGURE 34 NON-CLINICAL BENEFITS

FIGURE 35 WEARABLE MEDICAL DEVICES

FIGURE 36 FITNESS TRACKING DEVICES

FIGURE 37 TYPES OF MHEALTH SERVICES

FIGURE 38 TYPES OF APPS

FIGURE 39 BENEFITS OF BIG DATA

FIGURE 40 BENEFITS OF NETWORK & SERVICES

FIGURE 41 ROLES OF MOBILE OPERATORS

FIGURE 42 ROLE OF HEALTHCARE PROVIDERS

FIGURE 43 MHEALTH: MARKET BY THERAPEUTICS

FIGURE 44 BENEFITS OF MHEALTH IN CVDS

FIGURE 45 BENEFITS OF MHEALTH

FIGURE 46 BENEFITS OF MHEALTH

FIGURE 47 BENEFITS OF MHEALTH

FIGURE 48 BENEFITS OF MHEALTH

FIGURE 49 TYPES OF MHEALTH APPLICATION

FIGURE 50 ADVANTAGES OF REMOTE MONITORING

FIGURE 51 DIAGNOSIS AND TREATMENT SERVICES

FIGURE 52 EDUCATION & AWARENESS SERVICES

FIGURE 53 MHEALTH HEALTHCARE MANAGEMENT

FIGURE 54 GLOBAL MHEALTH MARKET CLASSIFICATION, BY GEOGRAPHY

FIGURE 55 APAC: MARKET DRIVERS

FIGURE 56 MHEALTH: PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS (2020)

FIGURE 57 MHEALTH: MERGERS & ACQUISITIONS (2020)

FIGURE 58 MHEALTH: KEY PRODUCT LAUNCH & DEVELOPMENTS (2020)

FIGURE 59 MHEALTH: KEY BUSINESS EXPANSIONS & CONTRACTS (2020)

FIGURE 60 MHEALTH: KEY PATENTS/APPROVALS (2020)

FIGURE 61 APPLE INC. OVERALL FINANCIALS ($BILLION), 2020-2027

FIGURE 62 APPLE INC.: NET REVENUE, BY SEGMENT, 2020-2027

FIGURE 63 APPLE INC.: NET REVENUE, BY REGION, 2020-2027

FIGURE 64 ATHENAHEALTH: OVERALL FINANCIALS, 2020-2027 ($MILLION)

FIGURE 65 ATHENAHEALTH: NET REVENUE, BY SEGMENT, 2020-2027 ($MILLION)

FIGURE 66 AT&T INC.: OVERALL FINANCIALS ($BILLION), 2020-2027

FIGURE 67 AT&T INC.: NET REVENUE BY SEGMENT, 2020-2027

FIGURE 68 BIOTELEMETRY INC.: OVERALL FINANCIALS ($BILLION), 2020-2027

FIGURE 69 BIOTELEMETRY INC.: NET REVENUE BY SEGMENTS ($MILLION), 2020-2027

FIGURE 70 GE CORPORATION: OVERALL FINANCIALS ($MILLION), 2020-2027

FIGURE 71 GE ELECTRONIC: NET REVENUE BY SEGMENTS ($MILLION), 2020-2027

FIGURE 72 GE HEALTHCARE SEGMENT, 2027

FIGURE 73 GOOGLE: OVERALL FINANCIALS, 2020 - 2027 ($BILLION)

FIGURE 74 J&J: OVERALL FINANCIALS, 2020 - 2027 ($ BILLION)

FIGURE 75 LABCORP OVERALL FINANCIALS ($MILLION), 2020-2027

FIGURE 76 NET REVENUE BY SEGMENTS, 2020-2027

FIGURE 77 NIKE: OVERALL FINANCIALS 2020 - 2027 ($BILLION)

FIGURE 78 NIKE: REVENUE BY REGION (2020-2027)

FIGURE 79 PFIZER: OVERALL FINANCIALS, 2020-2027 ($BILLION)

FIGURE 80 PFIZER: FINANCIALS BY SEGMENT, 2020-2027 ($MILLION)

FIGURE 81 PFIZER: FINANCIALS BY REGION, 2020-2027 ($BILLION)

FIGURE 82 PHILIPS: OVERALL FINANCIALS, 2020-2027 ($MILLION)

FIGURE 83 PHILIPS: FINANCIALS BY REGION, 2020-2027 ($MILLION)

FIGURE 84 PHILIPS: FINANCIALS BY SEGMENT, 2020-2027 ($MILLION)

FIGURE 85 QUALCOMM INC.: OVERALL FINANCIALS, 2020-2027 ($BILLION)

FIGURE 86 QUALCOMM INC.: NET REVENUE, BY SEGMENT, 2020-2027 ($MILLION)

FIGURE 87 QUALCOMM INC.: NET REVENUE, BY REGION, 2020-2027 ($MILLION)

FIGURE 88 QUEST: OVERALL FINANCIALS, 2020-2027 ($MILLION)

FIGURE 89 QUEST: NET REVENUE BY SEGMENTS, 2020-2027 ($MILLION)

FIGURE 90 ROCHE: OVERALL FINANCIALS, 2020-2027 ($BILLION)

FIGURE 91 ROCHE: NET REVENUE, BY SEGMENTS, 2020-2027 ($BILLION)

FIGURE 92 SAMSUNG ELECTRONICS CO. LTD.: OVERALL FINANCIALS ($BILLION), 2020-2027

FIGURE 93 SANOFI PHARMA: OVERALL FINANCIALS ($BILLION), 2020-2027

FIGURE 94 SANOFI PHARMA: NET REVENUE BY SEGMENT, 2020-2027